Clinical Biochemistry Practice Questions

Q: Which of the following conditions masks low serum haptoglobin in hemolysis?

Bile duct obstruction. **Explanation:** The primary clinical utility of **Haptoglobin** is as a marker for **intravascular hemolysis**. Haptoglobin is an acute-phase reactant synthesized by the liver that binds free hemoglobin. During hemolysis, haptoglobin levels drop significantly as it is cleared by the reticuloendothelial system. **Why Bile Duct Obstruction is correct:** Haptoglobin is a **positive acute-phase reactant**. In conditions like **bile duct obstruction (obstructive jaundice)**, inflammation or biliary stasis triggers an increase in the hepatic synthesis of haptoglobin. This elevation can artificially "mask" or normalize the low levels typically seen in hemolysis, leading to a false-negative result for hemolytic anemia. **Analysis of Incorrect Options:** * **Liver Disease:** Since haptoglobin is synthesized in the liver, severe liver disease (e.g., cirrhosis) leads to **decreased** production. This would mimic or exacerbate low levels rather than masking them. * **Malnutrition:** Protein-energy malnutrition leads to a generalized decrease in plasma protein synthesis, including haptoglobin, resulting in **low** levels. * **Pregnancy:** Pregnancy is associated with a physiological decrease in haptoglobin levels (estrogen effect), which would not mask a hemolytic state. **NEET-PG High-Yield Pearls:** * **Gold Standard for Hemolysis:** A **decreased** serum haptoglobin level is one of the most sensitive markers for confirming hemolysis. * **Acute Phase Reactants:** Remember that haptoglobin levels rise in infection, trauma, and malignancy, which can confound the diagnosis of co-existing hemolysis. * **Neonate Fact:** Haptoglobin levels are naturally very low or absent in newborns (physiologic ahaptoglobinemia) and reach adult levels by 6 months of age.

Q: Which of the following vitamin deficiencies is found in patients with gastric cancer?

Vitamin B12. **Explanation:** The correct answer is **Vitamin B12**. **Why Vitamin B12 is the correct answer:** Gastric cancer often involves the destruction or surgical resection of the gastric mucosa, specifically the **parietal cells** located in the body and fundus of the stomach. These cells are responsible for secreting **Intrinsic Factor (IF)**. Vitamin B12 (cobalamin) requires IF to form a complex that survives the acidic environment of the stomach and allows for absorption in the **terminal ileum**. In gastric cancer, the loss of parietal cells leads to IF deficiency, resulting in secondary Vitamin B12 malabsorption and potentially megaloblastic anemia (pernicious-like state). Additionally, the achlorhydria (lack of HCl) associated with gastric atrophy prevents the release of B12 from dietary proteins. **Why the other options are incorrect:** * **Vitamin C:** While low levels are associated with an increased *risk* of developing gastric cancer due to reduced antioxidant protection, the cancer itself does not characteristically cause a deficiency through a specific physiological mechanism like B12. * **Vitamin A & D:** These are fat-soluble vitamins. Their deficiency is typically associated with fat malabsorption syndromes (e.g., pancreatic insufficiency, biliary obstruction, or celiac disease) rather than the specific loss of gastric intrinsic factor. **High-Yield Clinical Pearls for NEET-PG:** * **Site of Absorption:** Vitamin B12 is absorbed in the **terminal ileum**, while Iron is absorbed in the **duodenum**. * **Post-Gastrectomy:** Patients undergoing total gastrectomy for gastric cancer *must* receive lifelong parenteral Vitamin B12 supplementation. * **Schilling Test:** Historically used to differentiate between causes of B12 deficiency (though largely replaced by antibody testing and metabolite levels). * **Associated Finding:** Look for **hypersegmented neutrophils** on a peripheral smear in patients with B12 deficiency.

Q: In carcinoma prostate with metastasis, which of the following biochemical markers is typically elevated?

Alkaline Phosphatase. **Explanation:** The correct answer is **Alkaline Phosphatase (ALP)**. In the context of prostate carcinoma, elevation of ALP is a hallmark of **osteoblastic (bone-forming) metastasis**. When prostate cancer cells spread to the bone, they stimulate osteoblasts to lay down new mineralized bone. ALP is a byproduct of osteoblastic activity; hence, its serum levels rise significantly as a marker of bone remodeling and turnover. **Analysis of Options:** * **Alkaline Phosphatase (Correct):** It is the most sensitive marker for detecting osteoblastic skeletal metastases in prostate cancer patients. * **Acid Phosphatase (Incorrect):** Specifically, Prostatic Acid Phosphatase (PAP) was historically used to diagnose prostate cancer. However, it is a marker of the **primary tumor burden** and soft tissue extension rather than bone metastasis specifically. It has largely been replaced by PSA (Prostate-Specific Antigen) in modern practice. * **ESR (Incorrect):** While ESR may be elevated in chronic malignancies or inflammation, it is a non-specific marker and not a diagnostic biochemical indicator for metastatic prostate cancer. * **Bilirubin (Incorrect):** Bilirubin is a marker of hepatobiliary disease or hemolysis and is not typically elevated in prostate cancer unless there is extensive, rare liver metastasis. **High-Yield Clinical Pearls for NEET-PG:** 1. **PSA (Prostate-Specific Antigen):** The most sensitive and specific marker for screening, monitoring, and detecting recurrence of prostate cancer. 2. **Osteoblastic vs. Osteolytic:** Prostate cancer typically causes **osteoblastic** lesions (High ALP), whereas Multiple Myeloma causes **osteolytic** lesions (Normal ALP). 3. **Acid Phosphatase:** If the question asks for a marker that correlates with the *volume* of the primary tumor or extra-capsular spread, PAP is the traditional answer.

Q: Which cardiac marker is elevated earliest in myocardial infarction?

Myoglobin. **Explanation:** The correct answer is **Myoglobin**. In the setting of an acute myocardial infarction (AMI), the timing of marker release depends on the molecule's size and its location within the cardiac cell. **1. Why Myoglobin is correct:** Myoglobin is a small heme protein found in the cytosol. Due to its low molecular weight, it is released rapidly into the bloodstream following membrane damage. It is the **earliest marker** to rise, typically appearing within **1–3 hours** of symptom onset and peaking at 6–9 hours. Its high sensitivity makes it excellent for "ruling out" an MI in the early stages if levels remain normal. **2. Why the other options are incorrect:** * **CPK-MB:** This isoenzyme begins to rise **4–6 hours** after injury. While it was previously the gold standard, it is now primarily used to detect **re-infarction** because it returns to baseline quickly (within 48–72 hours). * **Troponin I:** These are the most **specific** markers for cardiac injury. However, they begin to rise **3–6 hours** after the event, slightly later than myoglobin. They remain elevated for 7–10 days. * **LDH (Lactate Dehydrogenase):** This is a late marker. It begins to rise after **24 hours**, peaks at 3–4 days, and can stay elevated for up to 2 weeks. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Marker:** Myoglobin. * **Most Specific Marker:** Troponin I or T (Gold Standard). * **Marker for Re-infarction:** CPK-MB. * **Late Marker:** LDH (specifically the LDH-1 > LDH-2 "flipped pattern"). * **Window Period:** If a patient presents 12 hours after chest pain, Troponins are the most reliable; if they present within 2 hours, Myoglobin is the most sensitive.

Q: Which carbohydrate tumor marker is associated with breast cancer?

CA 15-3. **Explanation:** **CA 15-3 (Cancer Antigen 15-3)** is the correct answer. It is a carbohydrate antigen derived from the **MUC1 gene** product. In clinical practice, it is primarily used as a tumor marker for **breast cancer**. While it is not sensitive enough for screening early-stage disease, it is highly valuable for monitoring treatment response and detecting the recurrence or metastasis of breast malignancy. **Analysis of Incorrect Options:** * **CA 125:** This is the classic marker for **Ovarian Cancer** (specifically non-mucinous epithelial tumors). It can also be elevated in endometriosis, pelvic inflammatory disease, and pregnancy. * **CA 34:** This is not a standard clinical tumor marker used in the NEET-PG curriculum. It is likely a distractor. (Note: CD34 is a marker for hematopoietic stem cells and vascular endothelium). * **CA 19-9:** This is the primary marker for **Pancreatic Cancer** and cholangiocarcinoma. It is also associated with other gastrointestinal malignancies and obstructive jaundice. **High-Yield Clinical Pearls for NEET-PG:** * **CA 27-29:** Another marker frequently associated with breast cancer, often used interchangeably with CA 15-3. * **CEA (Carcinoembryonic Antigen):** While most famous for colorectal cancer, it is the second most common marker used to monitor breast cancer. * **HER2/neu:** A proto-oncogene (not a carbohydrate marker) used to determine prognosis and eligibility for Trastuzumab therapy in breast cancer patients. * **AFP (Alpha-fetoprotein):** Marker for Hepatocellular Carcinoma (HCC) and Yolk Sac Tumors. * **PSA (Prostate Specific Antigen):** Marker for Prostate Cancer.

Q: Which serum marker is the last to return to normal levels following a myocardial infarction?

Lactate dehydrogenase. ### Explanation The correct answer is **Lactate dehydrogenase (LDH)**. Following a myocardial infarction (MI), cardiac enzymes are released into the bloodstream at different rates and durations, which is critical for retrospective diagnosis. **1. Why Lactate Dehydrogenase (LDH) is correct:** LDH is a "late marker" of myocardial injury. It begins to rise 10–24 hours after the onset of chest pain, peaks at 48–72 hours, and remains elevated for **7 to 14 days**. Because of its long half-life, it is the last of the traditional markers to return to baseline, making it useful for diagnosing an MI that occurred several days prior. Specifically, the LDH-1 isoenzyme rises above LDH-2 (the "flipped pattern"). **2. Why the other options are incorrect:** * **Myoglobin:** This is the **earliest marker** to rise (within 1–3 hours) but is highly non-specific and returns to normal within **24 hours**. * **Creatine Phosphokinase (CPK-MB):** This is the gold standard for detecting **re-infarction**. It rises within 4–8 hours, peaks at 24 hours, and returns to normal within **48–72 hours**. * **Aspartate Transaminase (AST):** AST rises within 8–12 hours and returns to normal within **3–5 days**, much sooner than LDH. **3. High-Yield Clinical Pearls for NEET-PG:** * **Earliest Marker:** Myoglobin. * **Most Specific Marker:** Cardiac Troponin I (cTnI). * **Marker for Re-infarction:** CK-MB (due to its rapid rise and fall). * **Troponin Duration:** Troponin T can stay elevated for up to 10–14 days (similar to LDH), but in the context of traditional enzyme options, LDH is the classic answer for the "last to return to normal." * **LDH Flipped Pattern:** In healthy individuals, LDH-2 > LDH-1. In MI, LDH-1 > LDH-2.

Q: Increased 5-hydroxyindoleacetic acid in urine is seen in which of the following conditions?

Carcinoid syndrome. **Explanation:** **Correct Answer: C. Carcinoid syndrome** The underlying medical concept here is the metabolism of **Serotonin (5-HT)**. Carcinoid tumors, typically arising from enterochromaffin cells in the midgut, overproduce serotonin. In the body, serotonin is metabolized by the enzyme **Monoamine Oxidase (MAO)** into **5-hydroxyindoleacetic acid (5-HIAA)**, which is then excreted in the urine. Therefore, a 24-hour urinary 5-HIAA test is the gold-standard biochemical marker for diagnosing and monitoring Carcinoid syndrome. **Analysis of Incorrect Options:** * **A. Pheochromocytoma:** This is a tumor of the adrenal medulla characterized by excess catecholamines (Epinephrine/Norepinephrine). The urinary markers for this condition are **Vanillylmandellic acid (VMA)** and **Metanephrines**, not 5-HIAA. * **B. Ogilvie syndrome:** Also known as acute colonic pseudo-obstruction, this is a clinical condition involving massive dilation of the colon without mechanical obstruction. It has no specific biochemical association with serotonin metabolism. * **D. Tumor lysis syndrome:** This occurs due to rapid breakdown of cancer cells. It is characterized by hyperuricemia (increased **Uric acid**), hyperkalemia, hyperphosphatemia, and hypocalcemia. **High-Yield Clinical Pearls for NEET-PG:** * **Dietary Caution:** Patients must avoid serotonin-rich foods (bananas, walnuts, pineapples, avocados) for 72 hours before the 5-HIAA test to prevent false positives. * **Pellagra Connection:** In Carcinoid syndrome, up to 60% of dietary **Tryptophan** is diverted to serotonin synthesis (normally only 1%). This leads to a deficiency in Niacin (Vitamin B3) production, potentially causing **Pellagra** (Dermatitis, Diarrhea, Dementia). * **Clinical Triad:** Flushing, Diarrhea, and Right-sided heart failure (Tricuspid regurgitation/Pulmonary stenosis).

Q: Quantitative assessment of liver function can be done by:

Estimation of galactose elimination capacity. ### Explanation **1. Why the correct answer is right:** Most routine Liver Function Tests (LFTs) are actually markers of **liver injury** (enzymes) rather than true function. **Galactose Elimination Capacity (GEC)** is a dynamic test that measures the functional metabolic capacity of the liver. Galactose is phosphorylated almost exclusively by the liver (via galactokinase). By administering a standardized dose of galactose and measuring its clearance from the blood, clinicians can quantitatively assess the **functional hepatocyte mass**. It is particularly useful in chronic liver disease to predict prognosis and surgical risk. **2. Why the incorrect options are wrong:** * **Options A, B, and C (Transaminases, ALP, GGT):** These are **static biochemical markers** of cellular damage or cholestasis. * **Transaminases (ALT/AST)** indicate hepatocellular necrosis (leakage from damaged cells). * **ALP and GGT** are markers of cholestasis or biliary tree injury. * Crucially, these levels do not correlate with the actual "work" the liver is doing; for example, in end-stage cirrhosis, transaminases may be near normal because there are few hepatocytes left to leak enzymes. **3. Clinical Pearls for NEET-PG:** * **True Liver Function Tests:** These measure synthesis or clearance. Examples include **Serum Albumin**, **Prothrombin Time (PT/INR)**, and **Bilirubin**. * **Dynamic Tests:** Besides GEC, other quantitative tests include the **Indocyanine Green (ICG) clearance test** and the **Aminopyrine breath test**. * **Best indicator of acute liver liver failure prognosis:** Prothrombin Time (PT). * **Best indicator of liver's synthetic function (chronic):** Serum Albumin. * **Specific marker for Alcoholism:** GGT (Gamma-Glutamyl Transferase).

Question 1

Which of the following conditions masks low serum haptoglobin in hemolysis?

Accepted Answer

Bile duct obstruction

Answer

Liver disease

Answer

Malnutrition

Answer

Pregnancy

Question 2

Which of the following vitamin deficiencies is found in patients with gastric cancer?

Accepted Answer

Vitamin B12

Answer

Vitamin C

Answer

Vitamin A

Answer

Vitamin D

Question 3

In carcinoma prostate with metastasis, which of the following biochemical markers is typically elevated?

Accepted Answer

Alkaline Phosphatase

Answer

Erythrocyte Sedimentation Rate (ESR)

Answer

Acid Phosphatase

Answer

Bilirubin

Question 4

Which cardiac marker is elevated earliest in myocardial infarction?

Accepted Answer

Myoglobin

Answer

CPK-MB

Answer

LDH

Answer

Troponin I

Question 5

Which carbohydrate tumor marker is associated with breast cancer?

Accepted Answer

CA 15-3

Answer

CA 125

Answer

CA 34

Answer

CA 19-9

Question 6

In hepatic cirrhosis, which of the following protein fractions is typically increased in serum electrophoresis?

Accepted Answer

Gamma globulin

Answer

Alpha 1 globulin

Answer

Alpha 2 globulin

Answer

All of the above

Question 7

Which serum marker is the last to return to normal levels following a myocardial infarction?

Accepted Answer

Lactate dehydrogenase

Answer

Creatine phosphokinase

Answer

Aspartate transaminase

Answer

Myoglobin

Question 8

A patient presents with unconjugated hyperbilirubinemia and presence of urobilinogen in urine. Which amongst the following is the least likely diagnosis?

Accepted Answer

Hemolytic jaundice

Answer

Crigler-Najjar syndrome type 1

Answer

Gilbert's syndrome

Answer

Crigler-Najjar syndrome type 2

Question 9

Increased 5-hydroxyindoleacetic acid in urine is seen in which of the following conditions?

Accepted Answer

Carcinoid syndrome

Answer

Pheochromocytoma

Answer

Ogilvie syndrome

Answer

Tumor lysis syndrome

Question 10

Quantitative assessment of liver function can be done by:

Accepted Answer

Estimation of galactose elimination capacity

Answer

Degree of transaminases

Answer

Degree of alkaline phosphatase

Answer

Degree of GGT

Clinical Biochemistry — MCQs

Clinical Biochemistry — MCQs

On this page

Practice by Chapter

Want unlimited practice?